Clinical trial
Efficacy of Risperidone Versus Haloperidol in the Treatment of Aggression and Hostility in Psychotic Inmates
NCT00203775 is registered in ClinicalTrials.gov with University of Connecticut as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Risperidone Versus Haloperidol in the Treatment of Aggression and Hostility in Psychotic Inmates
- Lead sponsor
- University of Connecticut
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 31, 2002
- Completion date
- April 30, 2004
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aggression, psychosis